Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Blood Pressure01:24

Blood Pressure

The movement of blood in a human body, commonly referred to as blood flow, is determined by the volume of blood that traverses a certain section of the bodily system per unit time. It is the rhythmic contraction of the heart's ventricles that primarily instigates this movement. As the ventricles contract, blood is forced into the prominent arteries, which then flow from areas of greater pressure to lower pressure areas. This movement continues into smaller arteries and arterioles and...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The acute coronary syndrome revisited: effects and therapeutic modulation of excess metabolic fuel supply.

Cardiovascular journal of Africa·2020
Same author

Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF).

Life sciences·2018
Same author

Heart Disease in Marathon Runners.

The Physician and sportsmedicine·2017
Same author

The Value of Lactate and Pyruvate Measurements in the Assessment of the Redox State of Free Nicotinamide-Adenine Dinucleotide in the Cytoplasm of Perfused Rat Heart.

European journal of clinical investigation·2017
Same author

Beta-blockers for hypertension.

The Cochrane database of systematic reviews·2017
Same author

Melatonin has multiorgan effects.

European heart journal. Cardiovascular pharmacotherapy·2016

関連する実験動画

Updated: Jul 13, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

高血圧に関する論争

Norman M Kaplan1, Lionel H Opie

  • 1University of Texas Southwestern Medical Center, Dallas, TX, USA. norman.kaplan@utsouthwestern.edu

Lancet (London, England)
|January 18, 2006
PubMed
まとめ

高血圧は主要な心血管疾患の危険因子であり,発症率が上昇しています. このレビューは,ライフスタイルの変化,リスク評価,より良いコントロールのための薬物療法に焦点を当てて,管理における論争に対処しています.

科学分野:

  • 心臓病学 心臓病学
  • 公衆衛生は公衆衛生である.
  • 内科内科は,内科の内科である.

背景:

  • 高血圧は,心臓血管疾患と死亡率の主なリスク因子です.
  • 高齢化と肥満の集団における発生率が増加し,世界的な制御が不十分である.
  • 継続的な論争は,高血圧の効果的な管理を妨げています.

研究 の 目的:

  • 高血圧管理における主要な論争に対処するために.
  • 効果的な高血圧管理に関する医師のガイドラインを提供すること.
  • 高血圧の発生率の増加の理由と緩和戦略を探求する.

主な方法:

  • 既存の文献と臨床ガイドラインのレビュー.
  • リスク評価と薬物療法の開始に関する論争の議論.
  • 高血圧の発生と管理に影響を与える要因の分析.

主要な成果:

  • 特定された論争には,発生率の増加の理由,心血管リスク評価の必要性,薬物療法決定,原因のスクリーニングが含まれています.
  • 高血圧の進行を遅らせるために,ライフスタイルの変更が不可欠です.
  • 効果的な管理には,これらの複雑な問題への対処が必要です.

さらに関連する動画

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

関連する実験動画

Last Updated: Jul 13, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

結論:

  • 高血圧管理における論争の解決は,患者のアウトカムを改善するために不可欠です.
  • 医療従事者は,最適な患者ケアのための最新のガイドラインを必要としています.
  • リスク評価,ライフスタイルの変化,適切な薬物療法を含む包括的なアプローチが不可欠です.